Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-04-24 06:03 am Sale | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | Fosun International Ltd | 9,200,603 3% | -9,207,053 (-50.02%) | View |
2024-02-13 4:58 pm Purchase | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | VANGUARD GROUP INC | 13,642,387 4.45% | 594,319 (+4.55%) | View |
2024-01-05 4:09 pm Purchase | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | Mahesh Akram | 30,384,769 9.9% | 30,384,769 (New Position) | View |
2024-01-03 4:30 pm Sale | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Gautam | 2,025,454 0.07% | -31,859,952 (-94.02%) | View |
2023-12-12 06:04 am Unchanged | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | Fosun International Ltd | 18,407,656 6% | 0 (Unchanged) | View |
2023-12-01 4:15 pm Purchase | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Gautam | 33,885,406 11.1% | 3,073,298 (+9.97%) | View |
2023-11-08 5:07 pm Unchanged | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Chirag K. | 21,835,007 7.1% | 0 (Unchanged) | View |
2023-11-08 5:05 pm Unchanged | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Dipan | 26,905,073 8.8% | 0 (Unchanged) | View |
2023-11-08 5:03 pm Purchase | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Gautam | 30,812,108 10% | 17,497,336 (+131.41%) | View |
2023-11-08 4:59 pm Unchanged | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Chintu | 25,318,839 8.3% | 0 (Unchanged) | View |
2023-11-08 4:55 pm Unchanged | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Tushar Bhikhubhai | 53,578,209 17.5% | 0 (Unchanged) | View |
2023-10-17 7:32 pm Unchanged | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Dipan | 26,905,073 14.9% | 0 (Unchanged) | View |
2023-10-17 7:31 pm Purchase | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Chirag K. | 21,835,007 14.16% | 534,503 (+2.51%) | View |
2023-10-17 7:30 pm Purchase | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Chintu | 25,318,839 16.41% | 534,503 (+2.16%) | View |
2023-10-17 7:27 pm Unchanged | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Tushar Bhikhubhai | 53,578,209 25.8% | 0 (Unchanged) | View |
2023-10-17 7:25 pm Sale | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | Patel Gautam | 13,314,772 8.63% | -17,101,081 (-56.22%) | View |
2023-02-09 11:07 am Purchase | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | VANGUARD GROUP INC | 13,048,068 8.61% | 1,473,173 (+12.73%) | View |
2022-12-14 5:05 pm Sale | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | TPG GP A LLC | 12,328,767 8.1% | -3,884,600 (-23.96%) | View |
2022-02-09 3:24 pm Purchase | 13G | AMNEAL PHARMACEUTICALS INC CL AMRX | VANGUARD GROUP INC | 11,574,895 7.75% | 592,064 (+5.39%) | View |
2022-01-18 5:32 pm Purchase | 13D | AMNEAL PHARMACEUTICALS INC CL AMRX | TPG GP A LLC | 16,213,367 10.9% | 16,213,367 (New Position) | View |